secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2024-08-26T23:59:59+00:00
Accession:  0001493152-24-033876
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma receives Nasdaq non-compliance notice for late Q2 10-Q filing
----------------------------------------------------------------------------

- Nasdaq notified on Aug 21, 2024 of non-compliance with Listing Rule 5250(c)(1) due to delayed Q2 10-Q.
- Delay caused by re-audit of 2022 financials after SEC sanctions on former auditor B.F. Borgers CPA.
- Company expects to file amended 10-K/A for 2023 and amended Q1 10-Q in days, then Q2 10-Q to regain compliance.
- If more time needed, can submit compliance plan within 60 days for up to 180-day extension.
- Nasdaq notice has no immediate effect on listing of SHPH common stock on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224033876/0001493152-24-033876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224033876/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer